AEOLUS PHARMACEUTICALS, INC. | 2013 | FY | 3


As of September 30, 2013, warrants to purchase an aggregate of 17,879,627 shares of common stock were outstanding. Details of the warrants for common stock outstanding at September 30, 2013 were as follows:

 

Number of Shares  Exercise Price  Expiration Date
 100,000   $0.50   May 2014
 100,000   $1.00   May 2014
 100,000   $1.50   May 2014
 125,000   $0.51   June 2014
 125,000   $1.00   June 2014
 20,000   $0.39   September 2014
 15,000   $0.50   September 2014
 15,000   $0.60   September 2014
 50,000   $0.38   April 2015
 50,000   $0.50   May 2016
 50,000   $0.50   July 2016
 50,000   $1.00   July 2016
 50,000   $1.50   July 2016
 50,000   $2.00   July 2016
 50,000   $2.50   July 2016
 1,337,627   $0.40   March 2017
 325,000   $0.40   April 2017
 300,000   $0.258   June 2017
 140,000   $0.35   October 2017
 13,085,000   $0.25   February 2018
 1,742,000   $0.25   March 2018
 17,879,627         

 

 

As of September 30, 2012, warrants to purchase an aggregate of 62,132,626 shares of common stock were outstanding. Details of the warrants for common stock outstanding at September 30, 2012 were as follows:

 

Number of Shares  Exercise Price  Expiration Date
 100,000   $0.50   May 2014
 100,000   $1.00   May 2014
 100,000   $1.50   May 2014
 125,000   $0.65   June 2014
 125,000   $1.00   June 2014
 20,000   $0.39   September 2014
 15,000   $0.50   September 2014
 15,000   $0.60   September 2014
 50,000   $0.38   April 2015
 50,000   $0.50   May 2016
 50,000   $0.50   July 2016
 50,000   $1.00   July 2016
 50,000   $1.50   July 2016
 50,000   $2.00   July 2016
 50,000   $2.50   July 2016
 43,614,285   $0.28   October 2016
 1,337,627   $0.40   March 2017
 325,000   $0.40   April 2017
 300,000   $0.258   June 2017
 11,785,714   $0.28   July 2017
 35,000   $0.30   August 2017
 1,875,000   $0.50   August 2017
 35,000   $0.44   September 2017
 1,875,000   $0.50   December 2017
 62,132,626         

 

 


us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock